(Bloomberg) — The US Federal Reserve and a number of its global counterparts will launch a rapid-fire attack on inflation in the coming week as their commitment to bringing consumer prices under control gets ever more resolute. Three days of central-bank decisions are expected to deliver interest-rate hikes adding up to more than 500 basis […]
Read More(Bloomberg) — For investors burned by inflation, a very bad year is starting to look even worse. As stock prices tumbled and bonds were hit with the deepest losses in decades, the surge in consumer prices turned a few corners of the financial markets into profitable refuges earlier this year. Oil prices rallied. Other commodities […]
Read MoreSatsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. STSA $6.9200 0.4200 % 6.4600 Satsuma Pharmaceuticals Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 6.46% Wk: 7.96% Mo: 17.29% Yrly: 45.07% YTD: 53.78% Strength Rank: […]
Read More